Generic and Biosimilar Cancer Medicines
This Framework Agreement is for the supply of generic and biosimilar cancer medicines to NHS Scotland. The Goods have been separated into forty-one (41) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in section II.2 of this Notice.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Value
£59,145,973
Published
16 Sept 2022
Closes
17 Oct 2022
Procurement details
Source
Pcs
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Lot 1 Bendamustine Powder For Solution For Infusion
£94,841
Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 2 Lot 2 Capecitabine Tablets
£910,974
Supply of Capecitabine Tablets to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 3 Lot 3 Carboplatin Injection
£596,546
Supply of Carboplatin Injections to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 4 Lot 4 Cisplatin Injection
£186,020
Supply of Cisplatin Injections to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 5 Lot 5 Cyclophosphamide Injection, Powder For Reconstitution
£267,442
Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 6 Lot 6 Cytarabine Injections
£104,724
Supply of Cytarabine Injections to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 7 Lot 7 Dacarbazine Injections
£592,972
Supply of Dacarbazine Injections to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 8 Lot 8 Disodium Folinate Injection
£442,064
Supply of Disodium Folinate Injections to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 9 Lot 9 Docetaxel Concentrate For Solution For Infusion
£333,456
Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 10 Lot 10 Doxorubicin Hydrochloride Injections
£60,002
Supply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 11 Lot 11 Fluorouracil 25MG/ML Injection
£44,750
Supply of Fluorouracil 25MG/ML Injections to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 12 Lot 12 Fluorouracil 50MG/ML Injection
£236,261
Supply of Fluorouracil 50MG/ML Injections to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 13 Lot 13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials
£108,791
Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 14 Lot 14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials
£18,031
Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 15 Lot 15 Gemcitabine Powder For Solution For Infusion Vials
£125,603
Supply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Lot 16 Lot 16 Idarubicin Hydrochlioride Injection Powder For Reconstitution
£28,000
Supply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.
Delivery: Scotland
Documents
Unlock document linkGeneric and Biosimilar Cancer Medicines
Not provided
This Framework Agreement is for the supply of generic and biosimilar cancer medicines to NHS Scotland. The Goods have been separated into forty-one (41) categories, each of which is identified as a “Lot”. Full details of each Lot is contain...
Contract notice · Web page
Generic and Biosimilar Cancer Medicines
Not provided
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.